Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago Tottori, 683-8504, Japan.
Jpn J Ophthalmol. 2023 Jul;67(4):424-430. doi: 10.1007/s10384-023-01004-8. Epub 2023 Jun 21.
To determine the effect of the formulation of topical medications on the healing of corneal epithelial cells after phototherapeutic keratectomy (PTK).
Retrospective cohort study.
We studied 271 eyes of 189 consecutive patients (aged 67.6 ± 11.8 years) who had undergone PTK for granular corneal dystrophy (n = 140), band keratopathy (n = 47), or lattice corneal dystrophy (n = 2). Postoperatively, generic or brand-named levofloxacin, 0.1% betamethasone, or 0.1% bromfenac sodium hydrate was applied topically. Patients were examined on postoperative days 1, 2, and 5 and weekly thereafter. The time to re-epithelialization was assessed by use of Kaplan-Meier and Cox proportional hazards analyses.
The time to re-epithelialization was significantly longer with generic 0.5% levofloxacin, at 8.2 ± 3.5 days, than with 0.5% Cravit (levofloxacin), at 6.7 ± 3.5 days (P = 0.018), or with 1.5% Cravit, at 6.3 ± 2.6 days (P = 0.000). In addition, the time to re-epithelialization was significantly longer with generic 0.1% betamethasone (Sanbetason), at 7.3 ± 3.4 days, than with brand-name 0.1% betamethasone (Rinderon), at 6.1 ± 2.5 days (P = 0.0002). The Cox proportional hazards model indicated that the use of generic formulations for levofloxacin eye drops and 0.1% betamethasone was a significant factor that delayed corneal re-epithelialization (hazard ratio [HR] = 0.72, P = 0.002 and HR = 0.77, P = 0.006, after adjustment for age). Re-epithelialization was significantly shorter in band keratopathy than in corneal dystrophy (HR = 1.56, P = 0.004). No other factors, including age, bandage contact lens, and diabetes mellitus, were significantly associated with time to re-epithelialization.
Corneal epithelial healing can be significantly affected by different antibacterial or steroid eye drops. Clinicians need to be aware that a generic formulation may affect corneal epithelial healing.
确定光化学角膜切削术(PTK)后局部药物制剂对角膜上皮细胞愈合的影响。
回顾性队列研究。
我们研究了 189 例连续患者的 271 只眼(年龄 67.6±11.8 岁),这些患者因颗粒状角膜营养不良(n=140)、带状角膜病变(n=47)或格子状角膜营养不良(n=2)而行 PTK。术后,局部应用通用或品牌名左氧氟沙星、0.1%倍他米松或 0.1%溴芬酸钠水合物。术后第 1、2 和 5 天以及此后每周进行检查。使用 Kaplan-Meier 和 Cox 比例风险分析评估再上皮化时间。
与 0.5% Cravit(左氧氟沙星)组的 6.7±3.5 天相比,通用 0.5%左氧氟沙星组的再上皮化时间明显更长,为 8.2±3.5 天(P=0.018),与 1.5% Cravit 组的 6.3±2.6 天相比也更长(P=0.000)。此外,与品牌名 0.1%倍他米松(Rinderon)组的 6.1±2.5 天相比,通用 0.1%倍他米松(Sanbetason)组的再上皮化时间明显更长,为 7.3±3.4 天(P=0.0002)。Cox 比例风险模型表明,左氧氟沙星滴眼液和 0.1%倍他米松的通用制剂的使用是延迟角膜再上皮化的显著因素(调整年龄后,风险比[HR]分别为 0.72,P=0.002 和 HR=0.77,P=0.006)。与角膜营养不良相比,带状角膜病变的再上皮化时间明显更短(HR=1.56,P=0.004)。年龄、绷带接触镜和糖尿病等其他因素与再上皮化时间均无显著相关性。
不同的抗菌或皮质类固醇眼药水可显著影响角膜上皮愈合。临床医生需要注意,通用制剂可能会影响角膜上皮愈合。